Concepedia

Author

Youli Zu

Methodist HospitalORCID

Also Known As

Hsi, Eric D., Manyam, Ganiraju C., Ok, Chi Young, Tzankov, Alexandar, Van Krieken, J. Han, Y L Zu, Y Zu, Y.L. Zu, YOU‐LI ZU, Yanwen Zu

338

Publications

9.7K

Citations

48

H-Index

168

Concepts

All Affiliations

Methodist HospitalCornell UniversityMethodist HospitalThe University of Texas MD Anderson Cancer CenterHouston Methodist
YZ

About

Youli Zu is an author at Methodist Hospital specializing in medicine, immunology, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

35

63

3.4K

2

Engineering

11

11

895

3

Natural Sciences

8

8

424

4

Health Sciences

5

5

157

5

Biochemistry

2

2

120

Youli Zu

×

123

Publications

8.2K

Citations

47

H-Index

YearCitations

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

Shimin Hu, Zijun Y. Xu‐Monette, Alexandar Tzankov,

Blood

2013

671

Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy

Hongguang Sun, Xun Zhu, Patrick Lu,

Molecular Therapy — Nucleic Acids

2014

522

Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins

Catherine M. Bollard, Stephen Gottschalk, Vicky Torrano,

Journal of Clinical Oncology

2013

491

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

Zijun Y. Xu‐Monette, Lin Wu, Carlo Visco,

Blood

2012

383

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

Carlo Visco, Y Li, Zijun Y. Xu‐Monette,

Leukemia

2012

354

p38 Mitogen-Activated Protein Kinase Activation Is Required for Human Neutrophil Function Triggered by TNF-α or FMLP Stimulation

Youli Zu, Jiafan Qi, Annette Gilchrist,

The Journal of Immunology

1998

284

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

Shimin Hu, Zijun Y. Xu‐Monette, Aarthi Balasubramanyam,

Blood

2013

243

CRISPR-Cas9 delivery to hard-to-transfect cells via membrane deformation

Xin Han, Zongbin Liu, Myeong Chan Jo,

Science Advances

2015

227

Multiplexed volumetric bar-chart chip for point-of-care diagnostics

Yujun Song, Yuanqing Zhang, Paul E. Bernard,

Nature Communications

2012

216

Tumor-Specific T-Cells Engineered to Overcome Tumor Immune Evasion Induce Clinical Responses in Patients With Relapsed Hodgkin Lymphoma

Catherine M. Bollard, Tamara Tripic, Gianpietro Dotti,

Journal of Clinical Oncology

2018

172

Page 1